Sigma Delivers a Strong Full-Year Result With Non-PBS Revenue Increasing in the Mix
Narrow-moat Sigma Pharmaceuticals delivered a solid full-year result, with underlying net profit after tax of AUD 66.9 million broadly within expectations. The result was characterised by solid increases in Sigma-branded pharmacy sales and a significant improvement in working capital. We raise our fair value estimate by 4% to AUD 1.30 per share, from AUD 1.25 previously. The firm declared a full-year dividend of AUD 0.055, representing a 10% increase on the prior corresponding period, or PCP, an...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.